Related Experiment Videos
[Myocardial alterations with mechanical left ventricular assist devices]
F Grabellus1, C Schmid, B Levkau
1Institut für Pathologie, Universität Essen.
Der Pathologe
|April 4, 2003
Summary
Left ventricular assist devices (LVAD) can help heart failure patients. LVADs may reverse heart remodeling by reducing cardiac workload and improving blood flow, though mechanisms require further study.
Area of Science:
- Cardiology
- Biomedical Engineering
- Molecular Biology
Context:
- End-stage heart failure necessitates interventions like left ventricular assist devices (LVADs) as a bridge to transplantation.
- LVADs provide mechanical circulatory support, alleviating symptoms and improving hemodynamics in patients with severe cardiac dysfunction.
Purpose:
- To investigate the biological mechanisms underlying reverse remodeling in the human myocardium following long-term left ventricular assist device support.
- To explore the reversibility of molecular myocardial changes associated with heart failure under mechanical circulatory assistance.
Summary:
- Long-term LVAD support has been associated with reverse remodeling, a recovery of native ventricular function, but the underlying molecular mechanisms remain incompletely understood.
- Molecular pathways in the myocardium related to apoptosis, stress response, and matrix remodeling are altered in heart failure and show potential reversibility with LVAD support.
- Reduced volume and pressure overload, decreased ventricular wall stress, and improved myocardial blood supply due to LVADs are proposed explanations for observed molecular changes and reverse remodeling.
Impact:
- Understanding the mechanisms of reverse remodeling can optimize LVAD therapy and potentially lead to novel treatments for heart failure.
- This research contributes to the knowledge of myocardial adaptation to mechanical circulatory support, informing future therapeutic strategies.
- The findings may guide the development of interventions aimed at promoting myocardial recovery and improving long-term outcomes for heart failure patients.